Validation of Oncomine™ Immuno-Oncology NGS Assays at Q2 Solutions

Trends, Outcomes and Results

This presentation was given at ThermoFisher's Oncology network meeting in May 2019.

Download the presentation to learn:

  1. How Q2 Solutions leverages the ThermoFisher Oncomine™ Immuno-Oncology next generation sequencing (NGS) assays to support our translational research objectives
  2. Q2 Solutions validation trends, outcomes and results of the Oncomine™ Immuno-Oncology NGS assays